SARS-CoV-2

• New strategies for target vaccinations

• Therapies with monoclonal antibodies and antiviral drugs

• Long-COVID/PASC (post-acute sequelae of COVID)

HIV

• Precision medicine and individualized treatment options

• Long-term therapeutic efficacy and evaluation criteria

• New therapeutic strategies and advanced diagnostics for MDR and HTE

• The long-acting ART revolution

Monkeypox and other emerging infections

Vaccinations in the fragile population

Advanced diagnostics and therapy for antibiotic-resistance and fungal infections

Hepatitis

• The new diagnostic and therapeutic challenges

of Hepatitis B and D